Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials-Reference-Cited by-同舟云学术

Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials

Published:2021-05 Issue: Volume:148 Page:76-91
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Agostinetto Elisa,Eiger Daniel^ORCID,Lambertini Matteo^ORCID,Ceppi Marcello^ORCID,Bruzzone Marco,Pondé Noam,Plummer Chris^ORCID,Awada Ahmad H.,Santoro Armando,Piccart-Gebhart Martine,de Azambuja Evandro^ORCID

Funder

GlaxoSmithKline

Novartis

AstraZeneca

Janssen Pharmaceuticals

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Nivolumab in patients with relapsed or refractory hematologic malignancy: preliminary results of a phase Ib study;Lesokhin;J Clin Oncol Off J Am Soc Clin Oncol,2016

2. Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial;Younes;Lancet Oncol,2016

3. Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087;Chen;Blood,2019

4. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma;Larkin;N Engl J Med,2015

5. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma;Postow;N Engl J Med,2015

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitor–Induced Cardiotoxicity;JAMA Oncology;2024-08-22

2. Early identification of severe immune checkpoint inhibitor associated myocarditis: From an electrocardiographic perspective;Cancer Medicine;2024-07-31

3. Baricitinib protects ICIs-related myocarditis by targeting JAK1/STAT3 to regulate Macrophage polarization;Cytokine;2024-07

4. Immune Checkpoint Inhibitors and Cardiotoxicity: A Comparative Meta‐Analysis of Observational Studies and Randomized Controlled Trials;Journal of the American Heart Association;2024-05-21

5. Development of small molecule drugs targeting immune checkpoints;Cancer Biology & Medicine;2024-05-09